<DOC>
	<DOC>NCT00479466</DOC>
	<brief_summary>A study to compare MK0893 to metformin or placebo for patients with Type 2 diabetes (Diabetes Mellitus).</brief_summary>
	<brief_title>Dose-Range Finding Study for MK0893 (0893-008)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Patients who have Type 2 Diabetes Mellitus, with suboptimal glucose control, while either not on AHA (antihyperglycemic agent) therapy or on monotherapy or on lowdose combination therapy Patients have a history of Type 1 Diabetes Mellitus Patients taking insulin or thiazolidinedione (TZD, a peroxisome proliferatoractivated receptor [PPAR]gamma agonist) Patients who have a contraindication to metformin</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>